Affinity Determination by Adaptation of ProTein binders for Microfluidics enables rapid, parallel measurement of binding affinities and dissociation behavior directly from enriched display libraries in under one week, without requiring gene synthesis or hands-on protein purification.
Abstract
Protein-protein interactions underpin most cellular processes, and engineered binders present powerful tools for probing biology and developing novel therapeutics. However, scalable, quantitative characterization of large numbers of candidates remains a major bottleneck. Here we show that ADAPT-M (Affinity Determination by Adaptation of ProTein binders for Microfluidics) enables rapid, parallel measurement of binding affinities and dissociation behavior directly from enriched display libraries in under one week, without requiring gene synthesis or hands-on protein purification. Applied to a computationally designed library targeting the SARS-CoV-2 Omicron BA.1 receptor binding domain, ADAPT-M recovered most highly enriched variants and revealed that many display-enriched binders lacked measurable binding in vitro, highlighting limitations of screening alone. ADAPT-M enabled quantitative characterization of dozens of binders in parallel and selection of lead candidates for structural analysis. Unexpectedly, structural and mutational studies revealed that designed binding interfaces were preserved despite engaging alternative epitopes. By bridging screening and scalable in vitro validation, ADAPT-M accelerates protein binder discovery and supports data-driven protein engineering. ADAPT-M is a workflow combining design and high-throughput experimentation. It overcomes the testing bottleneck and enables rapid quantitative affinity measurements of thousands of designer proteins enriched from yeast surface display libraries.
A protocol for discovering protein‐binding peptides using a very large, target‐agnostic yeast surface display library containing approximately 6.1 × 109 unique clones and providing broad coverage of short peptide sequence space is described.
J. D. Hurley, Andrew C. Kruse· Current Protocols· 0 citations
The Human Bindome is presented, a proteome-scale atlas of high-confidence in silico protein binder candidates that positions the Bindome as a resource of genetically encodable perturbagens for site-specific, modular control of protein function.
Julius Wenckstern, Anna M. Díaz-Rovira, Julia A. Kuhn et al.· bioRxiv· 0 citations
MAXTIA is presented, a high‐throughput kinetic screening platform that integrates cell‐free protein synthesis with high‐throughput surface plasmon resonance and demonstrates its application to alanine scanning‐based functional epitope mapping, providing a simple and versatile platform for the quantitative analysis of p...
Kihoon Kim, Ryo Matsunaga, T. Yokoo et al.· Protein Science· 0 citations
This work presents a scalable mammalian cell-display workflow to identify AI-designed minibinders against cancer surface targets and identifies biochemical optimization beyond the binding interface as a critical requirement for translating AI-minibinders into functional applications.
B. Broske, B. McEnroe, S. C. Frechen et al.· Nature Communications· 1 citation
Various strategies to multimerize monomeric targets are explored, thus allowing them to be used as targets in this fragment discovery platform and a particularly effective and convenient strategy is to express a fusion of the POI with FOLDON, a 30-residue, homo-trimeric peptide.
Joel Tong, Isuru M. Jayalath, James V. Parsons et al.· RSC Chemical Biology· 0 citations
A high-throughput assay to identify small molecules that specifically inhibit a protein of interest in its nascent-chain form in its nascent-chain form is presented, providing a robust platform for larger-scale screening campaigns.
P. Fischer, Sebastian Hiller· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.